News
EAPH
0.0001
NaN%
--
Weekly Report: what happened at EAPH last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at EAPH last week (1117-1121)?
Weekly Report · 11/24 09:31
Weekly Report: what happened at EAPH last week (1110-1114)?
Weekly Report · 11/17 09:32
Weekly Report: what happened at EAPH last week (1103-1107)?
Weekly Report · 11/10 09:30
Weekly Report: what happened at EAPH last week (1027-1031)?
Weekly Report · 11/03 09:30
Weekly Report: what happened at EAPH last week (1020-1024)?
Weekly Report · 10/27 09:32
Weekly Report: what happened at EAPH last week (1013-1017)?
Weekly Report · 10/20 09:31
Weekly Report: what happened at EAPH last week (1006-1010)?
Weekly Report · 10/13 09:31
Weekly Report: what happened at EAPH last week (0929-1003)?
Weekly Report · 10/06 09:30
Weekly Report: what happened at EAPH last week (0922-0926)?
Weekly Report · 09/29 09:31
Weekly Report: what happened at EAPH last week (0915-0919)?
Weekly Report · 09/22 09:31
Weekly Report: what happened at EAPH last week (0908-0912)?
Weekly Report · 09/15 11:27
Weekly Report: what happened at EAPH last week (0901-0905)?
Weekly Report · 09/08 11:30
Weekly Report: what happened at EAPH last week (0825-0829)?
Weekly Report · 09/01 11:24
Weekly Report: what happened at EAPH last week (0818-0822)?
Weekly Report · 08/25 11:36
Weekly Report: what happened at EAPH last week (0811-0815)?
Weekly Report · 08/18 11:27
Weekly Report: what happened at EAPH last week (0804-0808)?
Weekly Report · 08/11 11:36
Weekly Report: what happened at EAPH last week (0728-0801)?
Weekly Report · 08/04 11:38
Weekly Report: what happened at EAPH last week (0721-0725)?
Weekly Report · 07/28 11:39
Weekly Report: what happened at EAPH last week (0714-0718)?
Weekly Report · 07/21 11:28
More
Webull provides a variety of real-time EAPH stock news. You can receive the latest news about Easton Pharma through multiple platforms. This information may help you make smarter investment decisions.
About EAPH
Parallel Industries Inc., formerly Easton Pharmaceuticals, Inc., is a development-stage company engaged in various pharmaceutical sectors and other industries. The Company has a transdermal delivery technology (Viorra Delivery Matrix or VDM), which is incorporated in a line of therapeutic over-the-counter (OTC) products. The Company owns topically-delivered drugs and therapeutic/cosmetic healthcare products focused on cancer and other health problems geared towards female sexual dysfunction, wound healing, pain, motion sickness and other conditions. The Company's products are in various stages of commercialization. The Company's products include Nauseasol, which is a motion sickness gel; Skin Renou HA, which is an anti-aging wrinkle cream; Kenestrin Gel, which is a pain relief gel; Viorra, which serves as an aid to the relief of female sexual arousal disorder (FSAD); XILIVE, which is an early-stage cancer drug, and FSAD) drug, which includes a water-based complex polymer matrix.